Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study

StatusActive, Not Recruiting
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Jan 2027 → Apr 2027
See other at-risk trials from Hexsel Dermatology Clinic

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date changed from estimate of Mar 2026 to Sep 1, 2026 Show 5 more changesShow less
    • Trial status changed: Not Yet Recruiting → Active, Not Recruiting
    • Primary completion pushed from Jan 2027 to Apr 2027
    • Study completion pushed from Mar 2027 to Sep 2027
    • Secondary endpoints: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 5 words
  2. Re-verified, no change to tracked fieldsv2
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
To evaluate the efficacy and safety of topical 2% tofacitinib nail lacquer in nail psoriasis, using the NAPSI and DLQI scales before and after 26 weeks of treatment.
Trial Details
NCT Number NCT07313072
Lead Sponsor Hexsel Dermatology Clinic
Conditions
(from sponsor)		 Nail Psoriasis
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov